Research graph
References from Outcomes of risankizumab use in adults with Crohn’s disease in a real-world setting (ARISE-CD): a multicentre, retrospective cohort study. Local targets link to admitted publications; unresolved targets remain external evidence.
Medical management of inflammatory bowel diseases
10.1136/bmj-2025-079050 · 2025 · External reference
Unresolved reference
External reference
10.1016/s0140-6736(22)00467-6
10.1016/s0140-6736(22)00467-6 · External reference
10.1016/s0140-6736(22)00466-4
10.1016/s0140-6736(22)00466-4 · External reference
A Core Outcome Set for Inflammatory Bowel Diseases: Development and Recommendations for Implementation in Clinical Practice Through an International Multi-stakeholder Consensus Process
2024 · External reference
10.1053/j.gastro.2020.12.031
10.1053/j.gastro.2020.12.031 · External reference
Unresolved reference
External reference
10.1056/nejmoa2314585
10.1056/nejmoa2314585 · External reference
Risankizumab is effective following ustekinumab failure in Crohn’s disease: A real-world study from a tertiary center
10.4292/wjgpt.v16.i4.110273 · 2025 · External reference
10.1093/ecco-jcc/jjaf070
10.1093/ecco-jcc/jjaf070 · External reference
Long-term Effectiveness and Safety of Risankizumab in Patients With Crohn’s Disease
10.1016/j.cgh.2024.09.027 · 2025 · External reference
Unresolved reference
External reference
Long-term Outcomes of Patients with Crohn’s Disease Treated with Risankizumab
10.1093/ibd/izaf162 · 2025 · External reference
10.1136/flgastro-2025-103449
10.1136/flgastro-2025-103449 · External reference
10.1093/ecco-jcc/jjaf231.1195
10.1093/ecco-jcc/jjaf231.1195 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1093/ecco-jcc/jjae186
10.1093/ecco-jcc/jjae186 · External reference
PWE-097 The Effect of Ethnicity on the Prevalence of Inflammatory Bowel Disease with the Luton and Dunstable Catchment Region, in UK
10.1136/gutjnl-2013-304907.385 · 2013 · External reference
Representation and reporting of diverse groups in randomised controlled trials of pharmacological agents in inflammatory bowel disease: a systematic review
10.1016/s2468-1253(23)00193-0 · 2023 · External reference
Inequalities in Healthcare Access, Experience and Outcomes in Adults With Inflammatory Bowel Disease: A Scoping Review
10.1093/ibd/izae077 · 2024 · External reference
Influence of biological sex in inflammatory bowel diseases
10.1038/s41575-025-01038-y · 2025 · External reference
Impact of Female Gender in Inflammatory Bowel Diseases: A Narrative Review
10.3390/jpm13020165 · 2023 · External reference
Unresolved reference
External reference
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects
10.1093/ecco-jcc/jjy114 · 2019 · External reference
A review of endoscopic scoring systems and their importance in a treat-to-target approach in inflammatory bowel disease (with videos)
10.1016/j.gie.2019.11.032 · 2020 · External reference
